Fluence Bioengineering, Inc. Sustainability Profile
Fluence Bioengineering, Inc., a leading name in the biotechnology sector, is headquartered in the United States and operates across various regions globally. Founded in 2015, the company has rapidly established itself as a pioneer in the development of innovative solutions for agricultural and environmental challenges. Fluence focuses on advanced bioengineering techniques, offering unique products and services that enhance plant growth and sustainability. Their proprietary technologies, including cutting-edge bioreactors and tailored nutrient solutions, set them apart in the competitive landscape. With a commitment to research and development, Fluence has achieved significant milestones, positioning itself as a key player in the bioengineering industry. Their dedication to improving crop yields and promoting sustainable practices has garnered recognition and respect within the scientific community.
DitchCarbon Score
How does Fluence Bioengineering, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Electrical Machinery Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fluence Bioengineering, Inc.'s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fluence Bioengineering, Inc., headquartered in the US, currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Signify N.V., which influences its climate commitments and initiatives. Fluence Bioengineering inherits its climate strategies from Signify N.V., which has established various sustainability initiatives, including targets set through the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 commitment to renewable energy. These initiatives aim to significantly reduce carbon emissions across their operations, although specific reduction targets for Fluence Bioengineering have not been disclosed. As part of its corporate family relationship with Signify N.V., Fluence Bioengineering aligns with industry-standard climate terminology and practices, focusing on sustainability and environmental responsibility. However, without specific emissions data or reduction targets, the company's individual climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 279,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 173,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | - | - |
| Scope 3 | 331,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 000,000,000,000 | 000,000,000,000 |
How Carbon Intensive is Fluence Bioengineering, Inc.'s Industry?
How Carbon Intensive is Fluence Bioengineering, Inc.'s Location?
Fluence Bioengineering, Inc.'s Scope 3 Categories Breakdown
Fluence Bioengineering, Inc.'s Scope 3 emissions, which decreased by 15% last year and increased significantly since 2014, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 99% of Scope 3 emissions.
Top Scope 3 Categories
Fluence Bioengineering, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fluence Bioengineering, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
